RxDoctor Payments Data

Joan D'cruz, APRN

Psychiatric/Mental Health · Kingsport, TNNPI 1558569426

Payments from drug & device makers

$1,099in general payments, 2019–2025

Across 71 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$299
  • AbbVie$291
  • Otsuka America Pharmaceutical, Inc.$126
  • Vanda Pharmaceuticals Inc.$91
  • Neurocrine Biosciences, Inc.$66
  • Axsome Therapeutics, Inc.$64
  • plus $162 from 7 others

What the payments were for

  • Food & beverage$1,099100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,099 in reported general payments places this provider in the 55th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$17,481
Medicare patients
47
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$52,617
VraylarCariprazine Hcl25$43,676
TrintellixVortioxetine Hydrobromide17$23,096
BelsomraSuvorexant11$4,970
Duloxetine Hcl156$4,448
Aripiprazole79$3,877
Desvenlafaxine Succinate ErDesvenlafaxine Succinate59$3,157
Trazodone Hcl97$2,893
Buspirone Hcl113$1,989
Vilazodone Hcl17$1,818
Quetiapine Fumarate136$1,568
Bupropion XlBupropion Hcl37$1,350
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$1,150
Venlafaxine Hcl ErVenlafaxine Hcl76$1,091
Bupropion Hcl SrBupropion Hcl40$973

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$23$52,61711 claims
AbbVieVraylar$291$43,67625 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$21$23,09617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →